We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$230B
AUM Growth
+$18.4B
Cap. Flow
-$8.18B
Cap. Flow %
-3.55%
Top 10 Hldgs %
23.04%
Holding
10,299
New
1,220
Increased
3,476
Reduced
4,117
Closed
1,266

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$615M
2
UBER icon
Uber
UBER
+$551M
3
EXPE icon
Expedia Group
EXPE
+$523M
4
PYPL icon
PayPal
PYPL
+$452M
5
ETN icon
Eaton
ETN
+$408M

Sector Composition

Rank Sector Weight
1 Technology 5.14%
2 Financials 4.52%
3 Industrials 4.17%
4 Healthcare 3.91%
5 Consumer Discretionary 3.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEL
8676
DELISTED
Cellcom Israel, Ltd.
CEL
$32K ﹤0.01%
+10,228
New +$27.7K
CNVS icon
8677
Cineverse
CNVS
$62.3M
$31K ﹤0.01%
+2,233
New +$38.5K
UAN icon
8678
CALL
CVR Partners
UAN
$1.34B
$31K ﹤0.01%
1,010
-180
-15% -$5.71K
APEN
8679
DELISTED
Apollo Endosurgery, Inc.
APEN
$31K ﹤0.01%
+10,758
New +$31.2K
SBBP
8680
DELISTED
Strongbridge Biopharma plc.
SBBP
$31K ﹤0.01%
+15,113
New +$29K
MACK
8681
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$31K ﹤0.01%
10,042
-3,587
-26% -$14.4K
ABUS icon
8682
CALL
Arbutus Biopharma
ABUS
$897M
$30K ﹤0.01%
+10,900
New +$17.6K
GIGM icon
8683
GigaMedia
GIGM
$15.8M
$30K ﹤0.01%
12,456
+1,078
+9% +$2.68K
QRHC icon
8684
Quest Resource Holding
QRHC
$26.8M
$30K ﹤0.01%
+13,869
New +$33.2K
SISI
8685
DELISTED
Shineco
SISI
0
XTKG
8686
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
0
AUC
8687
ATIF Holdings
AUC
$72.8M
$30K ﹤0.01%
170
-86
-34% -$20.3K
PSV
8688
DELISTED
Hermitage Offshore Services Ltd.
PSV
$30K ﹤0.01%
+29,156
New +$31.7K
CVIA
8689
CALL
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$30K ﹤0.01%
+14,800
New +$23.9K
MLNT
8690
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$30K ﹤0.01%
56,839
+41,984
+283% +$102K
AFMD
8691
PUT
DELISTED
Affimed
AFMD
$29K ﹤0.01%
1,060
-1,540
-59% -$41.2K
CLDX icon
8692
PUT
Celldex Therapeutics
CLDX
$3.26B
$29K ﹤0.01%
+13,000
New +$30.2K
IBIO icon
8693
iBio
IBIO
$69.1M
$29K ﹤0.01%
+236
New +$32K
JILL icon
8694
J. Jill
JILL
$280M
$29K ﹤0.01%
5,052
-510
-9% -$4K
KOSS icon
8695
Koss Corp
KOSS
$35.3M
$29K ﹤0.01%
+18,542
New +$31.6K
BACK
8696
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$29K ﹤0.01%
+635
New +$44.2K
YTEN
8697
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$29K ﹤0.01%
+175
New +$55.6K
EMAN
8698
DELISTED
eMagin Corporation
EMAN
$29K ﹤0.01%
83,964
+68,108
+430% +$22.8K
LGC.WS
8699
DELISTED
Legacy Acquisition Corp. Warrants, exercisable for one-half of one share of Class A Common Stock for
LGC.WS
$29K ﹤0.01%
53,497
-2,336
-4% -$1.04K
DLNG icon
8700
CALL
Dynagas LNG Partners
DLNG
$142M
$28K ﹤0.01%
+13,400
New +$27.4K

Similar funds

Citadel Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Citadel Advisors held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.1% of assets, down from 5.3% a quarter earlier, followed by Financials and Industrials.

Against the trend, Citadel Advisors opened a new position in Interxion Holding N.V. worth $83.9M.

  • Citadel Advisors's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
  • Citadel Advisors added most to Amazon in Q4 2019, an estimated $615M increase.
  • Citadel Advisors's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
  • Citadel Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
  • Citadel Advisors's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
  • Citadel Advisors opened 1,220 new positions and closed 1,266 in Q4 2019.
  • Citadel Advisors's portfolio value rose 8.7% quarter-over-quarter to $230B.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.